The Affimer platform has proven to be outstanding inside the laboratory. Avacta could be a titan in the making. That’s for sure.
Avacta – the next Roche?

Notes on a small investment portfolio
The Affimer platform has proven to be outstanding inside the laboratory. Avacta could be a titan in the making. That’s for sure.